We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,532

Does Buckman Preemption Apply to Antitrust and RICO Claims?
  • Reed Smith LLP
  • USA
  • April 5 2017

We talk a lot on this blog about Buckman preemption. That isn’t just out of pride regarding Bexis’s role in the bone screw litigation that led up to


DOJ Anti-Steering Suit Against Carolinas Healthcare Survives Preliminary Motion
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • April 3 2017

On March 30, 2017, in a closely watched case, a federal district court denied the Motion for Judgment on the Pleadings filed by Carolinas Healthcare


FTC to Keep Healthcare and Pharmaceutical Sectors in Antitrust Crosshairs
  • Duane Morris LLP
  • USA
  • April 3 2017

While the Trump Administration’s antitrust policy is still developing, and most believe it will provide for less enforcement than antitrust policy


Sidley Global Insurance Review - March 2017
  • Sidley Austin LLP
  • European Union, Germany, OECD, United Kingdom, USA
  • March 30 2017

The insurance industry has a global reach. Insurers and reinsurers are critically important to the world economy. They assume and transfer all manner


Pharmaceutical Antitrust Update: Courts Address How and When Product Hopping May Violate the Antirust Laws
  • Haug Partners LLP
  • USA
  • March 29 2017

For many companies that compete in competitive markets, innovation and product improvement fuels competitive success: create a better product than


House Votes to Repeal Antitrust Exemption for Health Insurers Under the Mccarran-Ferguson Act
  • Pepper Hamilton LLP
  • USA
  • March 29 2017

If the bill is passed, insurance carriers might be subject to challenges under both state and federal antitrust laws, including the Sherman Act, the


Government Solidifies Victory Blocking Chicago Hospital Merger
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 28 2017

The Federal Trade Commission (“FTC”) and the State of Illinois successfully concluded their challenge to the proposed merger of Advocate Health Care


House votes to eliminate antitrust exemption for health insurers
  • DLA Piper LLP
  • USA
  • March 27 2017

While the House of Representatives put repeal of the Affordable Care Act (ACA) on hold last week, it passed legislation that would eliminate the


Litigation Trends 2017
  • Weil Gotshal & Manges LLP
  • Global, United Kingdom, USA
  • March 27 2017

A recently proposed bill, if passed as introduced, would dramatically alter the class-action landscape in 2017 and beyond. Representative Bob


Repeal of Antitrust Immunity for Insurers: What Does It Mean?
  • Manatt Phelps & Phillips LLP
  • USA
  • March 23 2017

Insurers are among a handful of industries, including Major League Baseball, that have a special exemption from the federal antitrust laws, the